Codes / ICD10CM / T38.2X5

T38.2X5 Adverse effect of antithyroid drugs

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of antithyroid drugs

Summary

This condition refers to harmful or unintended reactions resulting from the use of antithyroid drugs, which are medications used to treat hyperthyroidism. The code applies when an adverse effect occurs due to therapeutic use of these drugs, excluding poisoning or underdosing scenarios.

Causes

Adverse effects arise from the pharmacological action of antithyroid drugs, such as methimazole or propylthiouracil, when used as prescribed. These reactions may stem from individual drug sensitivity, cumulative dosing, or interactions with other substances, even at standard therapeutic levels.

Risk Factors

  • Use of antithyroid drug therapies for hyperthyroidism
  • Prolonged or high-dose medication use
  • Pre-existing thyroid or autoimmune conditions
  • Concurrent use of other medications affecting thyroid function
  • Individual genetic or metabolic variations

Symptoms

Symptoms vary based on the specific drug and reaction type. Common effects include skin reactions (e.g., rash, pruritus), gastrointestinal issues (e.g., nausea, hepatitis), hematologic changes (e.g., agranulocytosis), or endocrine disturbances (e.g., hypothyroidism). Severe reactions may involve organ-specific toxicity.

Diagnosis

Diagnosis involves correlating clinical symptoms with medication history, including drug type, dose, and duration. Lab tests (e.g., thyroid function, liver enzymes, complete blood count) help identify organ involvement or metabolic changes. Exclusion of other causes is essential to confirm the adverse effect.

Treatment Options

Management focuses on discontinuing the offending drug, supportive care, and symptom-specific interventions. For mild reactions, observation or antihistamines may suffice. Severe cases require hospitalization, organ function support, and alternative therapies for hyperthyroidism.

Prognosis and Follow-Up

Prognosis depends on the severity and timeliness of intervention. Most mild reactions resolve with drug cessation, but severe toxicity (e.g., agranulocytosis) may have lasting effects. Follow-up includes monitoring thyroid function and organ health, with adjustments to treatment plans as needed.

Complications

Potential complications include persistent organ damage (e.g., liver failure), prolonged hypothyroidism, or life-threatening reactions like agranulocytosis. Delayed recognition may worsen outcomes, emphasizing the need for early intervention.

Lifestyle & Prevention

Patients should adhere to prescribed dosing, avoid self-adjusting medications, and report new symptoms promptly. Regular monitoring of thyroid function and organ health during therapy can help detect adverse effects early. Proper storage and education on drug use reduce risks.

When to Seek Professional Help

Seek immediate care for severe symptoms (e.g., fever, jaundice, unexplained bleeding) or signs of organ dysfunction. Contact a healthcare provider for persistent or worsening reactions, even if mild, to prevent escalation.

Tips for Medical Coders

Document the specific antithyroid drug involved, the nature of the adverse effect (e.g., dermatologic, hepatic), and the clinical context (e.g., therapeutic use). Ensure the code is not used for poisoning, underdosing, or intentional self-harm scenarios. Include details on symptom onset and management to support code assignment.

Book a walkthrough

T38.2X5 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.